FDA and FTC Encourage Biosimilar Competition

March 9, 2020

FDA and FTC Encourage Biosimilar Competition

The FDA and FTC signed a joint agreement supporting biosimilar market competition and describing steps both agencies will take to deter anticompetitive behavior. “Competition is key for helping American patients have access to affordable medicines,”said FDA Commissioner Stephen M. Hahn, M.D. Yourway is committed to moving and storing samples affordably on a global scale to increase patient access.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Global Clinical Supplies Group (GCSG)

October 14-16, 2025
Hungary, Budapest

Schedule a Meeting

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Schedule a Meeting

Media

Articles

Critical Packaging and Labeling Considerations for Decentralized Clinical Trials

Open chat

Hello! How can I help you?